Tl. Skaer et al., EFFECT OF PHARMACEUTICAL FORMULATION FOR ANTIHYPERTENSIVE THERAPY ON HEALTH-SERVICE UTILIZATION, Clinical therapeutics, 15(4), 1993, pp. 715-725
A significant factor in the management of hypertension is the extent t
o which patients comply with the treatment regimen. A retrospective an
alysis was undertaken to determine the relationship between antihypert
ensive formulation, regimen compliance, and the utilization of health
care services. Data for this analysis were derived from the state of S
outh Carolina's Medicaid computer archive. The study population consis
ted of 1000 randomly selected patients initially prescribed one of the
following antihypertensive regimens as monotherapy: atenolol once dai
ly, captopril BID, oral clonidine BID, transdermal clonidine once week
ly, diltiazem BID, enalapril BID, metoprolol BID, prazosin BID, terazo
sin once daily, and sustained-release verapamil once daily. Multivaria
te regression analysis was used to determine the incremental influence
of selected demographic characteristics, use of medical services befo
re diagnosis of hypertension, initial antihypertensive medication, med
ication possession ratio for antihypertensive therapy, and number of m
aintenance medications for diseases other than hypertension on post-pe
riod health care expenditures. The results indicated that patients ini
tially prescribed antihypertensive medication requiring once-daily or
once-weekly administration experienced an increased utilization of ant
ihypertensive medication, needed fewer changes in their therapeutic re
gimen, and far less need for concomitant therapy for blood pressure co
ntrol compared with those prescribed a BID regimen. Patients in the on
ce-daily or once-weekly groups also used significantly fewer physician
, hospital, and laboratory services (P less-than-or-equal-to 0.05).